Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dippe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Clinical Nutrition|November 1, 1972
Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administrationF D Hofeldt, S Dippe, P H Forsham
Diabetes|September 1, 1973
Personality disorder and reactive hypoglycemia. A quantitative studyD Anthony, S Dippe, F D Hofeldt, et al.
Military Medicine|December 1, 1975
Alimentary reactive hypoglycemia: effects of DBI and dilantin on insulin secretionF D Hofeldt, E G Lufkin, S F Hull, et al.
Controlled Clinical Trials|September 30, 1999
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)B I Freedman, J P Wuerth, K Cartwright, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Clinical Nutrition|November 1, 1972
Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administrationF D Hofeldt, S Dippe, P H Forsham
Diabetes|September 1, 1973
Personality disorder and reactive hypoglycemia. A quantitative studyD Anthony, S Dippe, F D Hofeldt, et al.
Military Medicine|December 1, 1975
Alimentary reactive hypoglycemia: effects of DBI and dilantin on insulin secretionF D Hofeldt, E G Lufkin, S F Hull, et al.
Controlled Clinical Trials|September 30, 1999
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)B I Freedman, J P Wuerth, K Cartwright, et al.
Pageof 1